Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maheshi N Ramasamy

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Nature Reviews. Neurology|August 7, 2024
Identifying and reducing risks of neurological complications associated with vaccinationLahiru Handunnetthi, Maheshi N Ramasamy, Lance Turtle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2014
Identification of antigen-specific B cell receptor sequences using public repertoire analysisJohannes Trück, Maheshi N Ramasamy, Jacob D Galson, et al.
Genome Medicine|February 1, 2017
High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccineDaniel O'Connor, Elizabeth A Clutterbuck, Amber J Thompson, et al.
Immunology and Cell Biology|May 16, 2015
BCR repertoire sequencing: different patterns of B-cell activation after two Meningococcal vaccinesJacob D Galson, Elizabeth A Clutterbuck, Johannes Trück, et al.
Vaccine|July 26, 2024
Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trialLucy R Williams, Katherine R W Emary, Daniel J Phillips, et al.
Clinical and Vaccine Immunology : CVI|June 27, 2014
Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdomMaheshi N Ramasamy, Elizabeth A Clutterbuck, Kathryn Haworth, et al.
BMJ Open|May 24, 2023
Accelerating clinical development of a live attenuated vaccine against <i>Salmonella</i> Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of <i>Salmonella</i> Paratyphi A infection in healthy adult volunteersNaina McCann, Katherine Emary, Nisha Singh, et al.
Vaccine|December 31, 2025
Enablers and barriers to participation in vaccine trials: a narrative synthesisNadia Daniel, Christine Smith, Nasima Miah, et al.
BMJ Open|November 25, 2025
Protocol for a phase IV, Experimental Human Pneumococcal Challenge (EHPC) model to investigate <i>Streptococcus pneumoniae</i> serotype 3 (SPN3) colonisation following PCV15, a double-blind randomised controlled trial in healthy participants aged 18-50 years in the UK (RATIONALE-15)Bruno Rocha de Macedo, Carla Solórzano, Angela Hyder-Wright, et al.
Ebiomedicine|September 4, 2025
Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trialBrama Hanumunthadu, Tesfaye Demissie, Melanie Greenland, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Nature Reviews. Neurology|August 7, 2024
Identifying and reducing risks of neurological complications associated with vaccinationLahiru Handunnetthi, Maheshi N Ramasamy, Lance Turtle, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 14, 2014
Identification of antigen-specific B cell receptor sequences using public repertoire analysisJohannes Trück, Maheshi N Ramasamy, Jacob D Galson, et al.
Genome Medicine|February 1, 2017
High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccineDaniel O'Connor, Elizabeth A Clutterbuck, Amber J Thompson, et al.
Immunology and Cell Biology|May 16, 2015
BCR repertoire sequencing: different patterns of B-cell activation after two Meningococcal vaccinesJacob D Galson, Elizabeth A Clutterbuck, Johannes Trück, et al.
Vaccine|July 26, 2024
Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trialLucy R Williams, Katherine R W Emary, Daniel J Phillips, et al.
Clinical and Vaccine Immunology : CVI|June 27, 2014
Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdomMaheshi N Ramasamy, Elizabeth A Clutterbuck, Kathryn Haworth, et al.
BMJ Open|May 24, 2023
Accelerating clinical development of a live attenuated vaccine against <i>Salmonella</i> Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of <i>Salmonella</i> Paratyphi A infection in healthy adult volunteersNaina McCann, Katherine Emary, Nisha Singh, et al.
Vaccine|December 31, 2025
Enablers and barriers to participation in vaccine trials: a narrative synthesisNadia Daniel, Christine Smith, Nasima Miah, et al.
BMJ Open|November 25, 2025
Protocol for a phase IV, Experimental Human Pneumococcal Challenge (EHPC) model to investigate <i>Streptococcus pneumoniae</i> serotype 3 (SPN3) colonisation following PCV15, a double-blind randomised controlled trial in healthy participants aged 18-50 years in the UK (RATIONALE-15)Bruno Rocha de Macedo, Carla Solórzano, Angela Hyder-Wright, et al.
Ebiomedicine|September 4, 2025
Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trialBrama Hanumunthadu, Tesfaye Demissie, Melanie Greenland, et al.
Pageof 4